• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Highbridge Capital Management Llc

    5/15/23 4:30:28 PM ET
    $XFIN
    Blank Checks
    Finance
    Get the next $XFIN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    HIGHBRIDGE CAPITAL MANAGEMENT LLC

    (Last) (First) (Middle)
    277 PARK AVE
    23RD FLOOR

    (Street)
    NEW YORK NY 10172

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ExcelFin Acquisition Corp. [ XFIN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/11/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Rule 10b5-1(c) Transaction Indication

      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock, par value $0.0001 per share 05/11/2023 S 81,175 D $10.32 418,315 I See footnotes(1)(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The securities reported herein are held by certain funds and accounts (the "Highbridge Funds") to which Highbridge Capital Management, LLC (the "Reporting Person"), a Delaware limited liability company, serves as investment adviser.
    2. The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
    Highbridge Capital Management, LLC, By: /s/ Kirk Rule, Executive Director 05/15/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $XFIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XFIN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XFIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baird Medical and ExcelFin Acquisition Corp Complete Business Combination

    NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China (which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances), and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ:XFIN), a publicly traded special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination"). The listed company resulting from the Business Combination is Baird Medical Investment Holdings Limited ("PubCo"), and its shares and warrants will commence trading on t

    10/1/24 5:37:00 PM ET
    $XFIN
    Blank Checks
    Finance

    Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement

    FORT MILL, S.C., Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ:XFIN), a publicly traded special purpose acquisition company, today announced that Baird Medical Investment Holdings Limited's ("PubCo") registration statement on Form F-4 (the "Registration Statement") related to their previously announced proposed business combination (the "Business Combination") has been declared effective by the U.S. Securities and Exchange Commission (the "SEC"). The declaration of effectiveness of the Registr

    9/5/24 5:23:00 PM ET
    $XFIN
    Blank Checks
    Finance

    Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders

    Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close Upon closing, Baird Medical is expected to trade on Nasdaq under the ticker symbol "BDMD"FORT MILL, S.C., March 12, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ:XFIN), a publicly traded special purpose acquisition company, today announced a strat

    3/12/24 7:00:00 AM ET
    $XFIN
    Blank Checks
    Finance

    $XFIN
    SEC Filings

    View All

    SEC Form 15-12G filed by ExcelFin Acquisition Corp

    15-12G - ExcelFin Acquisition Corp. (0001852749) (Filer)

    10/11/24 12:27:13 PM ET
    $XFIN
    Blank Checks
    Finance

    ExcelFin Acquisition Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ExcelFin Acquisition Corp. (0001852749) (Filer)

    9/27/24 4:51:15 PM ET
    $XFIN
    Blank Checks
    Finance

    ExcelFin Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ExcelFin Acquisition Corp. (0001852749) (Filer)

    9/26/24 12:06:19 PM ET
    $XFIN
    Blank Checks
    Finance

    $XFIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Highbridge Capital Management Llc

    4 - ExcelFin Acquisition Corp. (0001852749) (Issuer)

    5/15/23 4:30:28 PM ET
    $XFIN
    Blank Checks
    Finance

    SEC Form 4 filed by Highbridge Capital Management Llc

    4 - ExcelFin Acquisition Corp. (0001852749) (Issuer)

    5/8/23 4:15:27 PM ET
    $XFIN
    Blank Checks
    Finance

    SEC Form 4 filed by Highbridge Capital Management Llc

    4 - ExcelFin Acquisition Corp. (0001852749) (Issuer)

    5/2/23 4:15:40 PM ET
    $XFIN
    Blank Checks
    Finance

    $XFIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by ExcelFin Acquisition Corp (Amendment)

    SC 13G/A - ExcelFin Acquisition Corp. (0001852749) (Subject)

    2/14/24 9:12:34 AM ET
    $XFIN
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by ExcelFin Acquisition Corp (Amendment)

    SC 13G/A - ExcelFin Acquisition Corp. (0001852749) (Subject)

    2/14/24 6:31:56 AM ET
    $XFIN
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by ExcelFin Acquisition Corp (Amendment)

    SC 13G/A - ExcelFin Acquisition Corp. (0001852749) (Subject)

    2/9/24 8:53:37 AM ET
    $XFIN
    Blank Checks
    Finance